We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

30 hedge funds and large institutions have $19.5M invested in Biolase, Inc. in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

6% less funds holding

Funds holding: 32 → 30 (-2)

22% less capital invested

Capital invested by funds: $25.1M → $19.5M (-$5.59M)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Birchview Capital
Vermont
+$87.4K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$76.5K
3
TMC
Trellus Management Company
Florida
+$54.6K
4
OIM
Oracle Investment Management
Connecticut
+$43.7K
5
BFA
BlackRock Fund Advisors
California
+$10.9K

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$1.58M
2
Boston Partners
Boston Partners
Massachusetts
-$1.23M
3
EAM
Eagle Asset Management
Florida
-$1.01M
4
GTC
Ghost Tree Capital
New York
-$270K
5
SM
Sabby Management
Florida
-$255K

BIOL Hedge Fund Activity: Q4 2015 in Review

30 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2015, worth a combined $19.5M — down 22% from $25.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BIOL and 5 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Birchview Capital, adding an estimated $87.4K. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.58M sold.

  • 30 institutional investors held Biolase, Inc. (BIOL) as of Q4 2015, down from 32 in Q3 2015.
  • Funds reported $19.5M of Biolase, Inc. stock for Q4 2015, down 22% quarter-over-quarter.
  • 5 funds opened new Biolase, Inc. positions in Q4 2015 and 7 closed out, a net change of -2 holders.
  • The largest Biolase, Inc. buyer in Q4 2015 was Birchview Capital, an estimated $87.4K added.
  • The largest Biolase, Inc. seller in Q4 2015 was Visium Asset Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q4 2015.